US FDA grants emergency use authorisation to Regeneron antibody therapy given to Donald Trump


The green light for drugmaker Regeneron came after REGEN-COV2, was shown to reduce COVID-19-related hospitalizations or emergency room visits in patients with underlying conditions

Source

Leave a Reply

Your email address will not be published. Required fields are marked *